Metropolis Healthcare Ltd Share Price
(METROPOLIS)
Check the latest share price of Metropolis Healthcare Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹1704.8
as on 04:01PM, 29 Apr 2025
NSE
Metropolis Healthcare Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹1,700Day's Price Range₹1,753.952 Week's Low
52 Week's High
₹1,31552-Week Price Range₹2,318.3
| Returns % | |
| 1 Month Return | -0.23 % |
| 3 Month Return | -14.7 % |
| 1 Year Return | -9.9 % |
| Market Stats | |
| Previous Close | ₹1,748.80 |
| Open | ₹1,748.80 |
| Volume | 23.79K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,213.18Cr |
Metropolis Healthcare Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹8,213.18 Cr
Return on Equity (ROE)
25.82
Return on capital employed (ROCE)
28.73
P/B Ratio
12.65
Dividend Yield
0.39
EPS (TTM)
41.95
Sector
Healthcare
How to invest in Metropolis Healthcare Ltd
Investing in Metropolis Healthcare Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Metropolis Healthcare Ltd or METROPOLIS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Metropolis Healthcare Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Metropolis Healthcare Ltd with just a few clicks!
Metropolis Healthcare Ltd Valuation
Track how the P/E of Metropolis Healthcare Ltd has moved over time to understand valuation trends.
Metropolis Healthcare Ltd in the last 5 years
Lowest (33.38x)
June 22, 2022
Today (62.12x)
December 15, 2023
Industry (104.63x)
December 15, 2023
Highest (98.05x)
September 15, 2020
Today’s Price to Earnings Ratio: 62.12x
Analysts Recommendation on Metropolis Healthcare Ltd
Get updated buy, sell, and hold recommendations by analysts on Metropolis Healthcare Ltd.
based on 12 analysts
41.67%
Buy
16.67%
Hold
41.67%
Sell
41.67% of analysts recommend a 'HOLD' rating for Metropolis Healthcare Ltd. Average target of ₹1417.83
Source: S&P Global Market Intelligence
Analysts Forecast on Metropolis Healthcare Ltd
Get share price movements and forecasts by analysts on Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd price forecast by 12 analysts
Downside of
High
₹1610
Target
₹1417.83
Low
₹1087
Metropolis Healthcare Ltd target price ₹1417.83, a slight downside of -11.47% compared to current price of ₹1704.8. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Metropolis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2025:18.34%
Forecast
Actual
Including amortisation and stock based compensations
Metropolis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2025:35.20%
Forecast
Actual
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Financials
Get the annual and quarterly financial summary of Metropolis Healthcare Ltd, including revenue, profit, loss and more.
Metropolis Healthcare Ltd Index Inclusions
Metropolis Healthcare Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Metropolis Healthcare Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.75% | 0.00 | |
| Foreign Institutions | 25.67% | 0.00 | |
| Mutual Funds | 12.38% | 0.00 | |
| Retail Investors | 10.94% | 0.00 | |
| Others | 1.26% | 0.00 |
Metropolis Healthcare Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Metropolis Healthcare Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹8,213.18 Cr | 5.46% | 0.66 | NA | NA | |
| BUY | ₹9,908.51 Cr | 11.14% | 0.64 | NA | NA | |
| BUY | ₹3,718.29 Cr | 6.87% | 0.52 | NA | NA | |
| ₹22,584.81 Cr | 16.09% | 0.63 | NA | NA | ||
| HOLD | ₹32,670.61 Cr | 131.01% | 0.67 | NA | NA |
Metropolis Healthcare Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Metropolis Healthcare Ltd.
Diagnostic Sector Shows Resilience and Potential Consolidation - 24 Apr, 2025
Incumbents like Dr. Lal and Metropolis have regained margins to pre-COVID levels, indicating a positive outlook. However, consolidation in the diagnostic industry remains infrequent due to scale considerations.Metropolis Healthcare Faces Near-Term Challenges - 10 Apr, 2025
Metropolis Healthcare's stock has declined 21% over three months due to weak performance, earnings revisions, and regulatory concerns. Anticipated disappointing Q4 results and lower revenue growth add to the pressure, although some brokerages believe the stock has fully discounted these issues.Metropolis Expands Northern Presence with Acquisition - 07 Apr, 2025
Metropolis Healthcare has acquired Dr. Ahujas Pathology and Imaging Centre for ₹35 crore, enhancing its footprint in North India. This acquisition aligns with its growth strategy and aims to boost revenue and service offerings in the region.Metropolis Healthcare Reports 10% Revenue Growth in Q4 FY25 - 05 Apr, 2025
Metropolis Healthcare achieved a 10% year-on-year revenue growth in Q4 FY25, driven by its wellness segment, despite challenges in acute testing and specialty areas. The B2C business saw a 14% revenue increase, while operational EBITDA faced constraints from higher material costs. The company remains debt-free with cash reserves of Rs 112 crore, despite acquisition-related expenses.
Insights on Metropolis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 3.87% to 5.52% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, METROPOLIS stock has moved up by 14.7%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 26.37% to 26.42% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 54.9%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 165.8% return, outperforming this stock by 192.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 46.52 Cr → 31.36 Cr (in ₹), with an average decrease of 32.6% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 352.92 Cr → 325.32 Cr (in ₹), with an average decrease of 7.8% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.40% to 48.90% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.73% to 15.29% in Mar 2025 quarter
About Metropolis Healthcare Ltd
The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.
The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.
Revenue: ₹313.36Cr as on June 2024 (Q2 24)
Net Profit: ₹38.11Cr as on June 2024 (Q2 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
| Organisation | Metropolis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Metropolis Healthcare Ltd
Check out the Mutual Funds with significant holdings in Metropolis Healthcare Ltd.
Futures and Options
View the latest movement in Metropolis Healthcare Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Metropolis Healthcare Ltd price today?
Metropolis Healthcare Ltd share price today stands at ₹1704.8, Open: ₹1748.8, Previous Close: ₹1748.8, High: ₹1753.9, Low: ₹1700, 52 Week High: ₹2318.3, 52 Week Low: ₹1315.
How to Buy Metropolis Healthcare Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Metropolis Healthcare Ltd shares
What are today's traded volumes of Metropolis Healthcare Ltd?
Today's traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 23.79K.
What is today's market capitalisation of Metropolis Healthcare Ltd?
Today's market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹8,213.18 Cr.
What is the 52 Week High and Low Range of Metropolis Healthcare Ltd?
How much percentage Metropolis Healthcare Ltd is down from its 52 Week High?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1704.8. It is down -26.46% from its 52 Week High price of ₹2318.3
How much percentage Metropolis Healthcare Ltd is up from its 52 Week low?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1704.8. It is up 29.64% from its 52 Week Low price of ₹1315